A Wanaka woman connected to a company which was recently
licensed to manufacture synthetic drugs has had a change of
heart about the business.
Otago Daily Times sister newspaper The Lakes District
& Central Otago News reported yesterday B & K
Healtheries Ltd, incorporated on July 18 this year and
registered to a Wanaka address, had been granted interim
licences to import, manufacture, sell and research
psychoactive substances - the active ingredients in party
pills, energy pills and herbal highs.
Ministry of Health data shows the company has also been
licensed by the newly established Psychoactive Substances
Regulatory Authority to sell unapproved psychoactive
substances [to licensed manufacturers or researchers only,
not the general public], and has gained product approval for
its synthetic cannabis product ''Kush Pink''.
However, Kasey McMahon (23), of Wanaka, who is listed on the
Companies Office as B & K Healtheries sole director and
shareholder, told the Otago Daily Times yesterday she
had resigned as director and was no longer involved with the
''I've pulled out of it completely, 100%. I'm taking my name
off as director and the new director will be printed [on the
Companies Office website] next week.
''I have nothing to do with the company at all, just for
Ms McMahon declined to comment on who the new director would
be, but said the company would no longer be registered to an
address in Wanaka.
Asked if the company would continue to operate, Ms McMahon
said ''as far as I know''.
Attempts to track down the company's licence applicant,
Michael Forsyth, were unsuccessful.
The Psychoactive Substances Act 2013 states that if a licence
holder ceases to undertake the activity to which the licence
relates, the licence holder must surrender the licence to the
authority within 30 days.
B & K Healtheries' licences had not been surrendered, the
authority confirmed yesterday.
The application fee for approval of a psychoactive product is
$10,000, and each interim licence costs $500, amounting to
$13,000 in application fees for B & K Healtheries.
The 28-day application period for licences ended last month
and, while some applications remain under consideration, many
have already been issued.
The interim licence period will be phased out once
regulations under the Psychoactive Substances Act 2013 are
passed in the next few months.
Existing interim licence holders will have 28 days from that
date to make a decision on whether they wish to apply for a